Reuters
UK · 4 hrs ago
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo Reuters
Do you trust Reuters?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!